Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Merck
Cerilliant
UBS
Argus Health
Baxter
US Department of Justice
Chubb
Federal Trade Commission

Generated: April 23, 2018

DrugPatentWatch Database Preview

MERIDIA Drug Profile

« Back to Dashboard

Which patents cover Meridia, and when can generic versions of Meridia launch?

Meridia is a drug marketed by Abbott and is included in one NDA.

The generic ingredient in MERIDIA is sibutramine hydrochloride. There are six drug master file entries for this compound. Additional details are available on the sibutramine hydrochloride profile page.
Drug patent expirations by year for MERIDIA
Synonyms for MERIDIA
( inverted exclamation markA)-Sibutramine
(.+/-.)-1-(p-Chlorophenyl)-.alpha.-isobutyl-N,N-dimethylcyclobutanemethylamine
(+/-)-Sibutramine
(R)-DDMS
{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}dimethylamine
1-(1-(4-chlorophenyl)cyclobutyl)-N,N,3-trimethylbutan-1-amine
1-[1-(4-chlorophenyl)cyclobutyl]-N,N,3-trimethyl-1-butanamine
1-[1-(4-chlorophenyl)cyclobutyl]-N,N,3-trimethyl-butan-1-amine
1-[1-(4-chlorophenyl)cyclobutyl]-N,N,3-trimethylbutan-1-amine
106650-56-0
50S560
84485-00-7 (hydrochloride)
AB00949538_12
AB00949538-11
AB1009482
AC-15773
AC1L1JUC
AK-55514
AKOS004119970
AKOS022060500
AN-33835
ANW-68883
API0004168
BBL010956
BC209517
BDBM84742
BSPBio_002737
BTS 54524
BTS-54524
Butramin
Butramin (TN)
C07247
CAS_106650-56-0
CCG-101166
CHEBI:9137
CHEMBL1419
CPD000238156
CTK8C2703
CYC087
Cyclobutanemethanamine, 1-(4-chlorophenyl)-N,N-dimethyl-|A-(2-methylpropyl)-
Cyclobutanemethanamine, 1-(4-chlorophenyl)-N,N-dimethyl-alpha-(2-methylpropyl)-
D08513
D08KVZ
DB01105
DEA No. 1675
didemethyl sibutramine HCl
didemethyl sibutramine hydrochloride
DR000958
DTXSID1023578
Ectiva (TN)
FT-0082832
FT-0658720
GTPL2586
HMS2052P05
HMS2090N17
HMS2272C06
HMS3394P05
HSDB 7209
I05-0006
KBio2_002508
KBio2_005076
KBio2_007644
KBio3_001957
KBioGR_001653
KBioSS_002516
LS-172014
MCULE-6656338642
Medaria
Meridia (TN)
MLS001066619
MLS001401362
N-1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutyl-N,N-dimethylamine HCl
NC00416
NCGC00092357-02
NCGC00092357-04
NSC_5210
OR113663
OR209162
racemic sibutramine
Reductil
Reductil (TN)
SAM001247105
SBI-0206737.P001
SC-77376
SCHEMBL2955
Sibutramina
Sibutramina [Spanish]
sibutramine
Sibutramine (INN)
Sibutramine [INN:BAN]
Sibutramine hydrochloride
Sibutramine-d6
Sibutraminehydrochloride
Sibutraminum
Sibutraminum [Latin]
SMR000238156
SPBio_001612
Spectrum_001961
Spectrum2_001686
Spectrum3_001009
Spectrum4_001137
Spectrum5_001440
STK802066
STOCK4S-20116
TC-157628
TL8000239
UNAANXDKBXWMLN-UHFFFAOYSA-N

US Patents and Regulatory Information for MERIDIA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott MERIDIA sibutramine hydrochloride CAPSULE;ORAL 020632-001 Nov 22, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Abbott MERIDIA sibutramine hydrochloride CAPSULE;ORAL 020632-002 Nov 22, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Abbott MERIDIA sibutramine hydrochloride CAPSULE;ORAL 020632-003 Nov 22, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for MERIDIA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott MERIDIA sibutramine hydrochloride CAPSULE;ORAL 020632-003 Nov 22, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Abbott MERIDIA sibutramine hydrochloride CAPSULE;ORAL 020632-003 Nov 22, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Abbott MERIDIA sibutramine hydrochloride CAPSULE;ORAL 020632-001 Nov 22, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Abbott MERIDIA sibutramine hydrochloride CAPSULE;ORAL 020632-002 Nov 22, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for MERIDIA
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Capsules 10 mg and 15 mg ➤ Subscribe 2009-08-14

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Colorcon
Julphar
Argus Health
Deloitte
Farmers Insurance
Teva
US Army
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.